Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

11 Feb 2010 07:00

RNS Number : 9787G
Halma PLC
11 February 2010
 



Halma p.l.c.

 

Interim Management Statement

 

11 February 2010

 

 

Halma, the leading safety, health and sensor technology group today makes an Interim Management Statement prior to its financial year end on 3 April 2010. This Interim Management Statement covers the period from 4 October 2009 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles) for the full year to be higher than the top of the range of market expectations. The Board believes the current range of market expectations is £78.9million to £82.1million (2008/09 profit before amortisation of acquired intangibles: £79.1million).

 

During the past four-month period, average weekly revenue was 3% higher than we reported for the first half-year ending 3 October 2009. Order intake was ahead of revenue, continuing the positive trend of the first half. The impact of currency exchange rate movements has been broadly neutral relative to the first half.

 

In recent months, profitability has improved in all our three sectors, each benefiting from the actions taken earlier in 2009 to reduce fixed and variable costs.

 

Health and Analysis continues to perform strongly and is expected to report growth in both revenue and profit for the full year. Demand levels in Infrastructure Sensors have continued to be resilient and this, combined with a lower cost base, should enable it to achieve profit growth for the full year. In Industrial Safety, trading has improved gradually although full year revenue and profit are still expected to be below last year's record levels.

 

On 22 January 2010, we announced the acquisition of SphereOptics, LLC for an initial cash consideration of $2.5m (£1.5m) with a deferred purchase consideration of up to $3.5m (£2.1m) based on the growth in profit before tax for the period ending March 2012. SphereOptics manufactures and distributes precision products for use in high technology light measurement applications. Its integration within our Health and Analysis business is proceeding to plan.

 

There have been no material events or transactions impacting the Group's financial position which remains robust and cash generation continues to be strong. We remain well placed to acquire businesses which meet our demanding requirements.

 

The results for the financial year ending 3 April 2010 are expected to be released on 22 June 2010.

 

 

For further information, please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

 

Hogarth Partnership Limited

Rachel Hirst/Andrew Jaques

 

Tel: +44 (0)20 7357 9477

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMZVGRGGZM
Date   Source Headline
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition
17th Jan 20227:00 amRNS2021 AGM – Voting Results Update Statement
30th Nov 20211:05 pmRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSAcquisition
18th Nov 20217:00 amRNSHalf Year Results
15th Nov 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.